Medtronic's smallest CoreValve heart device wins EU approval

09/27/2012 | (Boston)

European regulators have granted Medtronic CE mark approval to market CoreValve Evolut, a 23-millimeter transcatheter aortic valve. The implantable device, which is the smallest from the firm's CoreValve line, offers a minimally invasive treatment alternative to heart disease patients who are not fit for open-heart surgery.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC